Aehr Test Systems Stock Forecast, Price & News

Aehr Test Systems (NASDAQ:AEHR) Frequently Asked Questions

Is Aehr Test Systems a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aehr Test Systems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Aehr Test Systems stock.
View analyst ratings for Aehr Test Systems or view top-rated stocks.

How has Aehr Test Systems' stock been impacted by COVID-19 (Coronavirus)?

Aehr Test Systems' stock was trading at $1.65 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AEHR shares have increased by 834.5% and is now trading at $15.42.
View which stocks have been most impacted by COVID-19.

Are investors shorting Aehr Test Systems?

Aehr Test Systems saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,240,000 shares, a decline of 23.0% from the October 31st total of 1,610,000 shares. Based on an average trading volume of 4,380,000 shares, the short-interest ratio is presently 0.3 days.
View Aehr Test Systems' Short Interest.

When is Aehr Test Systems' next earnings date?

Aehr Test Systems is scheduled to release its next quarterly earnings announcement on Thursday, January 6th 2022.
View our earnings forecast for Aehr Test Systems.

How were Aehr Test Systems' earnings last quarter?

Aehr Test Systems (NASDAQ:AEHR) posted its quarterly earnings data on Wednesday, September, 22nd. The semiconductor company reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The semiconductor company earned $5.65 million during the quarter. Aehr Test Systems had a negative net margin of 7.11% and a negative trailing twelve-month return on equity of 26.71%.
View Aehr Test Systems' earnings history.

What guidance has Aehr Test Systems issued on next quarter's earnings?

Aehr Test Systems issued an update on its FY 2022 earnings guidance on Thursday, October, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $50 M-, compared to the consensus revenue estimate of $28.42 million.

What price target have analysts set for AEHR?

1 analysts have issued 12-month price targets for Aehr Test Systems' shares. Their forecasts range from $31.00 to $31.00. On average, they anticipate Aehr Test Systems' stock price to reach $31.00 in the next year. This suggests a possible upside of 101.0% from the stock's current price.
View analysts' price targets for Aehr Test Systems or view top-rated stocks among Wall Street analysts.

Who are Aehr Test Systems' key executives?

Aehr Test Systems' management team includes the following people:

• Gayn Erickson, President, Chief Executive Officer & Director (LinkedIn Profile)
• Michael Brannan, Vice President-Operations
• Kenneth B. Spink, VP, Chief Financial & Accounting Officer (LinkedIn Profile)
• David S. Hendrickson, Chief Technology Officer
• Donald P. Richmond, Vice President-Engineering

What is Rhea J. Posedel's approval rating as Aehr Test Systems' CEO?

1 employees have rated Aehr Test Systems CEO Rhea J. Posedel on Glassdoor.com. Rhea J. Posedel has an approval rating of 100% among Aehr Test Systems' employees. This puts Rhea J. Posedel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Aehr Test Systems' key competitors?

Some companies that are related to Aehr Test Systems include Cohu (COHU), Transcat (TRNS), Allied Motion Technologies (AMOT), inTEST (INTT), Frequency Electronics (FEIM), Data I/O (DAIO), Reliability (RLBY), Orbit /Fr (ORFR), Giga-tronics (GIGA) and Electric & Gas Technology (ELGT).
View all of AEHR's competitors.

What other stocks do shareholders of Aehr Test Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aehr Test Systems investors own include Arbutus Biopharma (ABUS), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Vaxart (VXRT), Aclaris Therapeutics (ACRS) and Acasti Pharma (ACST).

What is Aehr Test Systems' stock symbol?

Aehr Test Systems trades on the NASDAQ under the ticker symbol "AEHR."

Who are Aehr Test Systems' major shareholders?

Aehr Test Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include Collaborative Holdings Management LP (4.65%), EAM Investors LLC (1.57%), EAM Global Investors LLC (0.91%), Geode Capital Management LLC (0.70%), BlackRock Inc. (0.65%) and Voloridge Investment Management LLC (0.62%). Company insiders that own Aehr Test Systems stock include David Fucci, David S Hendrickson, Donald P Richmond II, Gayn Erickson, Geoffrey Gates Scott, Howard T Slayen, Kenneth B Spink, Kenneth B Spink, Kunio Sano, Laura Oliphant, Michael A Brannan, Rhea J Posedel and Rhea J Posedel.
View institutional ownership trends for Aehr Test Systems.

Which major investors are selling Aehr Test Systems stock?

AEHR stock was sold by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., and Raymond James Financial Services Advisors Inc.. Company insiders that have sold Aehr Test Systems company stock in the last year include David S Hendrickson, Donald P Richmond II, Gayn Erickson, Geoffrey Gates Scott, Howard T Slayen, Kenneth B Spink, Laura Oliphant, Michael A Brannan, and Rhea J Posedel.
View insider buying and selling activity for Aehr Test Systems or view top insider-selling stocks.

Which major investors are buying Aehr Test Systems stock?

AEHR stock was bought by a variety of institutional investors in the last quarter, including Collaborative Holdings Management LP, EAM Investors LLC, EAM Global Investors LLC, Voloridge Investment Management LLC, BlackRock Inc., Morgan Stanley, Citadel Advisors LLC, and New York State Common Retirement Fund.
View insider buying and selling activity for Aehr Test Systems or or view top insider-buying stocks.

How do I buy shares of Aehr Test Systems?

Shares of AEHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aehr Test Systems' stock price today?

One share of AEHR stock can currently be purchased for approximately $15.42.

How much money does Aehr Test Systems make?

Aehr Test Systems has a market capitalization of $409.56 million and generates $16.60 million in revenue each year. The semiconductor company earns $-2.03 million in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does Aehr Test Systems have?

Aehr Test Systems employs 71 workers across the globe.

What is Aehr Test Systems' official website?

The official website for Aehr Test Systems is www.aehr.com.

Where are Aehr Test Systems' headquarters?

Aehr Test Systems is headquartered at 400 KATO TERRACE, FREMONT CA, 94539.

How can I contact Aehr Test Systems?

Aehr Test Systems' mailing address is 400 KATO TERRACE, FREMONT CA, 94539. The semiconductor company can be reached via phone at (510) 623-9400, via email at [email protected], or via fax at 510-623-9450.